These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Soluble P-selectin - a marker of platelet activation and vessel wall injury: increase of soluble P-selectin in plasma of patients with myocardial infarction, massive atherosclerosis and primary pulmonary hypertension]. Semenov AV, Kogan-Ponomarev MIa, Ruda MIa, Komarov AL, Panchenko EP, Chazova IE, Mazurov AV. Ter Arkh; 2000 May; 72(4):15-20. PubMed ID: 10833791 [Abstract] [Full Text] [Related]
43. Decreased stabilization of prostacyclin activity in patients with bone tumors. Mehta P, Ostrowski N, Brigmon L. Cancer Res; 1984 Jul; 44(7):3132-4. PubMed ID: 6373003 [Abstract] [Full Text] [Related]
44. [Evaluation of platelet hemostasis in patients with chronic renal failure]. Krawczyk W, Dmoszyńska A, Sokołowska B. Wiad Lek; 1994 Feb; 47(3-4):93-9. PubMed ID: 7975649 [Abstract] [Full Text] [Related]
45. Ventilatory and cardiovascular effects of prostacyclin and 6-oxo-PGF1 alpha by inhalation. Parsargiklian M, Bianco S. Adv Prostaglandin Thromboxane Res; 1980 Feb; 7():943-51. PubMed ID: 6989209 [No Abstract] [Full Text] [Related]
51. Platelet surface receptor activation in patients with chronic renal failure on hemodialysis, peritoneal dialysis and those with successful kidney transplantation. Ballow A, Gader AM, Huraib S, Al-Husaini K, Mutwalli A, Al-Wakeel J. Platelets; 2005 Feb; 16(1):19-24. PubMed ID: 15763892 [Abstract] [Full Text] [Related]
52. Effect of prostacyclin on platelets, polymorphonuclear cells, and heterotypic cell aggregation during hemofiltration. Kozek-Langenecker SA, Spiss CK, Michalek-Sauberer A, Felfernig M, Zimpfer M. Crit Care Med; 2003 Mar; 31(3):864-8. PubMed ID: 12626998 [Abstract] [Full Text] [Related]
53. The behaviour of various platelet function tests during long-term prostacyclin infusion in patients with peripheral vascular disease. Sinzinger H, Horsch AK, Silberbauer K. Thromb Haemost; 1983 Dec 30; 50(4):885-7. PubMed ID: 6229898 [Abstract] [Full Text] [Related]
54. Plasma thromboxane and prostacyclin metabolites in sheep partial cardiopulmonary bypass. Zapol WM, Peterson MB, Wonders TR, Kong D, Watkins WD. Trans Am Soc Artif Intern Organs; 1980 Dec 30; 26():556-60. PubMed ID: 7018060 [No Abstract] [Full Text] [Related]
55. Lidocaine increases prostacyclin in the rat. Casey LC, Armstrong MC, Fletcher JR, Ramwell PW. Prostaglandins; 1980 Jun 30; 19(6):977-84. PubMed ID: 6992240 [Abstract] [Full Text] [Related]
56. An imbalance between the excretion of thromboxane and prostacyclin metabolites in women after the menopause. Jendryczko A, Tomala J. Zentralbl Gynakol; 1993 Jun 30; 115(4):163-6. PubMed ID: 8503234 [Abstract] [Full Text] [Related]
58. [Comparison of biocompatibility of hemophane, cellulose diacetate and acrilonitile membranes in hemodialysis]. Germin Petrović D. Acta Med Croatica; 2004 Jun 30; 58(1):31-6. PubMed ID: 15125391 [Abstract] [Full Text] [Related]
59. Effects of quercetin on platelet and reperfusion-induced arrhythmias in rats. Xiao D, Gu ZL, Qian ZN. Zhongguo Yao Li Xue Bao; 1993 Nov 30; 14(6):505-8. PubMed ID: 8010047 [Abstract] [Full Text] [Related]
60. Evaluation of prostaglandin D2 (PGD2) as an anticoagulative agent for haemodialysis in comparison with prostaglandin E1 (PGE1). Nakagawa S, Matsui N, Akiba T, Shinoda T, Fukudome Y, Ozawa K, Baba M, Nakanishi T, Takeuchi J. Proc Eur Dial Transplant Assoc; 1981 Nov 30; 18():117-21. PubMed ID: 7036145 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]